CClinicalTrials.gg
Not yet recruitingNCT07065045Updated Jul 15, 2025

Psychometric Properties Of Translated Arabic Version Of The Fremantle Shoulder Awareness Questionnaire In Patients With Chronic Shoulder Pain

An observational study in Chronic Shoulder Pain, sponsored by Cairo University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-15.

Sponsored by Cairo University · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2026, 8 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

Test the psychometric properties of translated arabic version of the Fremantle shoulder awareness questionnaire in patients with chronic shoulder pain

02

Conditions studied

  • Chronic Shoulder Pain
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients with chronic shoulder pain will be aged 18 or more years old . Shoulder pain lasting for more than three months who, after clinical evaluation, will be positive in at least three of the following six clinical tests: (1) Hawkins impingement sign; (2) Neer's impingement sign; (3) painful arc sign; (4) Jobe's test; (5) Whipple's test; (6) shoulder pain elicited by resistance testing during shoulder abduction or external rotation.

Being conscious and oriented. Able to read and write in Arabic.

Inclusion criteria

  • Patients with chronic shoulder pain was aged 18 or more years old .
  • Shoulder pain lasting for more than three months which, after clinical evaluation, was positive in at least three of the following six clinical tests: (1) Hawkins impingement sign; (2) Neer's impingement sign; (3) painful arc sign; (4) Jobe's test; (5) Whipple's test; (6) shoulder pain elicited by resistance testing during shoulder abduction or external rotation.
  • Being conscious and oriented.
  • Able to read and write in Arabic.

Exclusion criteria

Exclusion Criteria:

  • History of shoulder surgery or planned shoulder surgery.
  • History of fracture, dislocation, or degenerative disease of the shoulder joint.
  • Active shoulder range of motion \<90 degrees of flexion or abduction or \<0 degrees of external rotation.
  • Cervical radiculopathy or examination that caused shoulder pain/reduced range of motion after repetitive neck movements.
  • Other serious orthopedic problems.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patient with chronic shoulder pain

    Patients with chronic shoulder pain will be aged 18 or more years old . Shoulder pain lasting for more than three months who, after clinical evaluation, will be positive in at least three of the following six clinical tests: (1) Hawkins impingement sign; (2) Neer's impingement sign; (3) painful arc sign; (4) Jobe's test; (5) Whipple's test; (6) shoulder pain elicited by resistance testing during shoulder abduction or external rotation. Being conscious and oriented. Able to read and write in Arabic.

06

What researchers measure

Primary outcomes

  1. validity

    questionnaires will be given to chronic painful shoulder patients. Face validity and content validity will be tested by asking physiotherapists who are experienced for \> five years if arabic version of the fremantle shoulder awareness questionnaire is easy to use and its contents relevant to the title. construct validity will be tested by applying questionnaires to patients with chronic shoulder pain as gold standard: cross-culturally adapted arabic version of the fremantle shoulder awareness questionnaire(score 0-36, Higher scores indicate greater levels of disturbed bodily self-awareness),Pain Visual Analogue Scale(score 0-100, higher score indicates greater pain intensity), the Quick Disabilities of the Arm, Shoulder and Hand questionnaire(score 0-100 and higher score indicates greater disability),the Shoulder Pain and Disability Index (score 0-10, higher score indicates pain and disability) and the Pain Catastrophizing Scale(score 0-52, higher score indicates high pain perception)

    Time frame: One week

  2. Reliability

    The participants will fill in the Fremantle shoulder awareness questionnaire Arabic version again after 5-7 days without any intervening physical therapy session between those two occasions and at the same time of day to assess the test-retest reliability of the scale. Its overall score ranges from 0-36. Higher scores are associated with greater levels of disturbed bodily self-awareness

    Time frame: one week

  3. feasibility (the time needed to fill out the translated Arabic version of the fremantle shoulder awareness questionnaire.)

    The researcher will calculate the time needed to fill out the translated Arabic version of the fremantle shoulder awareness questionnaire.

    Time frame: one week

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07065045
Lead sponsor
Cairo University
Responsible party
salma khamis mohamed El-gazzar (principal investigator, Cairo University) — Principal investigator
First posted
Jul 15, 2025
Start date
Sep 1, 2025 (estimated)
Primary completion
Jan 30, 2026 (estimated)
Completion
Feb 15, 2026 (estimated)
Last update
Jul 15, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion